Ceritinib Treatment for Recurrent Meningiomas | MicrobiomeTrials← Back to trialsNCT07893197
Ceritinib Treatment for Recurrent Meningiomas
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2027-01Est. Completion: 2031-01
Enrollment target: 10 participants Locations- Montreal Neurological Institute-Hospital, Montreal, Canada
Other microbiome trials you might be interested in
Meningioma
The objective of the study is to evaluate efficacy and safety of zanzalintinib in participants with recurrent or progres…
Birmingham, United StatesEst. completion Feb 29, 2028
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic MeningiomaAnaplastic OligodendrogliomaBrain Stem GliomaEpendymoblastomaGiant Cell Glioblastoma
Glioblastoma
Gliosarcoma
Grade III Meningioma
Meningeal Hemangiopericytoma
Mixed Glioma
Pineal Gland Astrocytoma
Brain Tumor
RATIONALE: Biological therapies, such as cellular adoptive immunotherapy, may stimulate the immune system in different w…
Duarte, United StatesCompleted Sep 23, 2013